---
title: "Maitreya Medicare Ltd (MAITREYA) — Share Price, Financials & Analysis"
symbol: "MAITREYA"
company: "Maitreya Medicare Ltd"
canonical: "https://tapetide.com/stocks/MAITREYA"
isin: "INE0PLQ01011"
nse_symbol: "MAITREYA"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 81.99
generated_at: "2026-09-13T18:57:36.923Z"
---

# Maitreya Medicare Ltd (MAITREYA)

Canonical page: https://tapetide.com/stocks/MAITREYA

## Company

- **NSE Symbol:** MAITREYA
- **ISIN:** INE0PLQ01011
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2023-11-07
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** maitreyahospitals.com

## About

Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]

## Latest Price

- **Price:** ₹116
- **Change:** -5 (-4.13%)
- **Open:** ₹114.05
- **Day High:** ₹120
- **Day Low:** ₹114.05
- **Previous Close:** ₹121
- **Volume:** 1600
- **As Of:** 2026-09-11T09:59:10+00:00

## Key Fundamentals

Observed at 2026-09-11T04:34:23.730081Z.

- **Market Cap:** ₹81.99 Cr
- **Classification:** SME
- **P/E (reported):** -33.2
- **Book Value:** ₹35.8
- **Price to Book:** 3.38
- **Dividend Yield:** 0%
- **ROE:** 5.7%
- **ROCE:** 10.79%
- **Debt to Equity:** 0.8
- **Revenue (yearly):** ₹44.85 Cr
- **Net Income:** ₹-2.41 Cr
- **EBITDA:** ₹-0.45 Cr
- **52-Week High:** ₹292.95
- **52-Week Low:** ₹107.5
- **RSI (14):** 50.42

## Tapetide Score

- **Score:** 39 / 100
- **Score date:** 2026-09-04
- **Archetype:** Expensive and Under Pressure
- **What it means:** The multiple is demanding and the trend has turned against it, without the financial strength that would justify paying up. What matters is whether the de-rating stops at the multiple or starts showing up in the numbers.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Falling
- **Percentile:** 12 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 33.38 | 9% |
| growth | 36.92 | 9% |
| momentum | 6.48 | 12% |
| ownership | 50 | 24% |
| quality | 52.12 | 22% |
| valuation | 33.5 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 2.71 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -4.32% over past five years.
- Company has a low return on equity of 3.28% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 302.4% | 95.37% | 13.71% |
| ebitda margin growth | -128% | -108.48% | -107.51% | -113.19% |
| net income growth | -168.75% | -226.84% | -180.33% | -319.09% |
| revenue growth | 5.93% | -4.98% | 5% | -4% |
| roce | -146.85% | -24.01% | -63.41% | 20.86% |
| roe | -167.72% | -41.72% | 14.28% | -87.11% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 24.79 | 23.01 | 24.36 | 22.3 | 23.7 | 21.15 |
| Expenses | 20.23 | 21.85 | 21.18 | 20.6 | 22.66 | 22.64 |
| Operating Profit | 4.56 | 1.16 | 3.18 | 1.7 | 1.04 | -1.49 |
| OPM % | 18.39 | 5.04 | 13.05 | 7.62 | 4.39 | -7.04 |
| Other Income | 0.05 | 0.22 | 0.19 | 0.38 | 0.23 | 0.76 |
| Interest | 0.39 | 0.46 | 0.45 | 0.35 | 0.43 | 1.06 |
| Depreciation | 0.64 | 0.64 | 0.66 | 0.84 | 0.79 | 0.73 |
| Profit before tax | 3.58 | 0.28 | 2.26 | 0.89 | 0.05 | -2.52 |
| Tax % | 28.49 | 67.86 | 26.11 | 83.15 | 160 | -3.97 |
| Net Profit | 2.56 | 0.09 | 1.67 | 0.15 | -0.04 | -2.43 |
| EPS in Rs | 5.16 | 0.13 | 2.46 | 0.22 | -0.06 | -3.59 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 55.93 | 49.35 | 39.28 | 46.08 | 44.98 | 44.85 |
| Expenses | 48.68 | 45.98 | 32.02 | 40.08 | 40.1 | 45.31 |
| Operating Profit | 7.25 | 3.37 | 7.26 | 6 | 4.88 | -0.46 |
| OPM % | 12.96 | 6.83 | 18.48 | 13.02 | 10.85 | -1.03 |
| Other Income | 0.43 | 0.33 | 0.53 | 0.3 | 0.57 | 0.99 |
| Interest | 0.82 | 0.78 | 0.57 | 0.84 | 0.8 | 1.48 |
| Depreciation | 1.09 | 1.32 | 1.29 | 1.27 | 1.44 | 1.52 |
| Profit before tax | 5.77 | 1.6 | 5.93 | 4.19 | 3.21 | -2.47 |
| Tax % | 26.52 | 28.75 | 28.16 | 29.12 | 41.74 | 0 |
| Net Profit | 4.24 | 1.14 | 4.25 | 2.97 | 1.87 | -2.47 |
| EPS in Rs | 4240 | 1140 | 8.57 | 4.38 | 2.76 | -3.65 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 0.01 | 4.96 | 6.78 | 6.78 | 11.55 |
| Reserves | 3.85 | 4.7 | 3.81 | 18.07 | 19.94 | 17.48 |
| Borrowings | 14.24 | 12.38 | 11.59 | 11.1 | 10.53 | 23.12 |
| Other Liabilities | 7.17 | 7.4 | 8.55 | 7.91 | 10.75 | 16.29 |
| Total Liabilities | 25.27 | 24.49 | 28.91 | 43.86 | 48 | 68.44 |
| Fixed Assets | 13.84 | 13.4 | 11.6 | 14.32 | 15.26 | 40.81 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1.07 | 0.32 | 0.68 | 1.47 | 0.04 | 0.05 |
| Other Assets | 10.36 | 10.77 | 16.63 | 28.07 | 32.7 | 27.58 |
| Total Assets | 25.27 | 24.49 | 28.91 | 43.86 | 48 | 68.44 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4.45 | 0.08 | 2.59 | -2.5 | 5.06 | 8.45 |
| Cash from Investing Activity | -5.07 | -0.02 | 0.36 | -5.44 | -7.37 | -26.74 |
| Cash from Financing Activity | 2.16 | -1.86 | -1.59 | 12.21 | 3.67 | 19.04 |
| Net Cash Flow | 1.55 | -1.8 | 1.36 | 4.27 | 1.36 | 0.75 |
| Free Cash Flow | -1.17 | -0.82 | 3.16 | -4.11 | 2.68 | -18.63 |
| CFO/OP | 77 | 54 | 40 | -12 | 134 | -1863 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 31.91 | 43.42 | 90.41 | 108.52 | 121.4 | 89.68 |
| Inventory Days | 68.78 | 40.82 | 69.86 | 40.26 | 36.56 | 32.07 |
| Days Payable | 258.06 | 221.84 | 319.59 | 207.25 | 199.54 | 153.1 |
| Cash Conversion Cycle | -157.37 | -137.61 | -159.32 | -58.47 | -41.58 | -31.35 |
| Working Capital Days | -4.11 | 3.11 | 43.12 | 73.43 | 73.68 | -9.93 |
| ROCE % | — | 12.33 | 32.85 | 17.3 | 10.77 | -2.18 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 73.11% | 73.11% | 73.11% | 73.11% | 73.11% |
| FIIs | 2.53% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 19.52% | 22.34% | 22.01% | 21.54% | 21.64% |
| Others | 4.84% | 4.55% | 4.88% | 5.35% | 5.25% |
| No. of Shareholders | 474 | 907 | 986 | 978 | 976 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 7 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 119.03 | Sell |
| EMA (10) | 118.71 | Sell |
| SMA (20) | 117.65 | Sell |
| EMA (20) | 119.11 | Sell |
| SMA (50) | 123.82 | Sell |
| EMA (50) | 126.83 | Sell |
| SMA (100) | 145.59 | Sell |
| EMA (100) | 144.11 | Sell |
| SMA (200) | 181.85 | Sell |
| EMA (200) | 174.74 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 45.72 | Neutral |
| MACD (12,26,9) | -1.39 | Buy |
| Stochastic (14,3,3) | 43.6 | Neutral |
| ADX (14) | 18.46 | Neutral |
| Williams %R (14) | -70.9 | Neutral |
| ATR (14) | 8.67 | High Volatility |
| ROC (12) | 3.34 | Buy |
| Stoch RSI (14) | 38.61 | Neutral |
| UO (7,14,28) | 37.75 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 March 2026 - Subsidiary Maitreya Hospital inaugurated 125-bed multispecialty unit in Valsad effective 08-Mar-2026; total beds now 675. | [Updates 9 March 2026 - Subsidiary Maitreya Hospital inaugurated 125-bed multispecialty unit in Valsad effective 08-Mar-2026; total beds now 675.](https://nsearchives.nseindia.com/corporate/MAITREYA_09032026111850_INTIMATION_TO_STOCK_EXCHANGE.pdf) |
| 9 January 2026 - Certificate confirming dematerialisation processing for quarter ended December 31, 2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 January 2026 - Certificate confirming dematerialisation processing for quarter ended December 31, 2025.](https://nsearchives.nseindia.com/corporate/MAITREYA_09012026130753_REG74_5_.pdf) |
| 7 April 2026 - Submitted SDD compliance certificate for FY ended 31 March 2026; no non-compliance reported. | [Structural Digital Database 7 April 2026 - Submitted SDD compliance certificate for FY ended 31 March 2026; no non-compliance reported.](https://nsearchives.nseindia.com/corporate/MAITREYA_07042026153322_SDD_COMPLIANCE_CERTIFICATE.pdf) |
| 7 April 2026 - Regulation 74(5) certificate received for quarter and year ended March 31, 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 7 April 2026 - Regulation 74(5) certificate received for quarter and year ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/MAITREYA_07042026125738_REG_74_5_-_COVERING_LETTER.pdf) |
| 6 Jul - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 6 Jul - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026.](https://nsearchives.nseindia.com/corporate/MAITREYA_06072026160402_REG_74_5_.pdf) |
| 30 May - Reported no deviation in IPO proceeds use for half year ended March 31, 2026; Rs.1489.12 lakh raised. | [Statement of deviation(s) or variation(s) under Reg. 32 30 May - Reported no deviation in IPO proceeds use for half year ended March 31, 2026; Rs.1489.12 lakh raised.](https://nsearchives.nseindia.com/corporate/MAITREYA_30052026113124_SOD.pdf) |
| 29 May 2026 - Board re-appointed JDM and Associates LLP as Secretarial Auditor for FY 2026-27 on May 29, 2026. | [Appointment 29 May 2026 - Board re-appointed JDM and Associates LLP as Secretarial Auditor for FY 2026-27 on May 29, 2026.](https://nsearchives.nseindia.com/corporate/MAITREYA_29052026190833_SECRETARIAL_AUDITOR.pdf) |
| 29 May 2026 - Board approved FY26 audited results, auditor appointments, WTD resignation effective May 25, 2026, and redemption of 90,000 preference shares. | [Outcome of Board Meeting 29 May 2026 - Board approved FY26 audited results, auditor appointments, WTD resignation effective May 25, 2026, and redemption of 90,000 preference shares.](https://nsearchives.nseindia.com/corporate/MAITREYA_29052026164004_MML_FINANCIAL_RESULTS.pdf) |
| 29 May - Maitreya Medicare appointed R P V & Company as internal auditor for FY2026-27 on 29 May 2026. | [Appointment 29 May - Maitreya Medicare appointed R P V & Company as internal auditor for FY2026-27 on 29 May 2026.](https://nsearchives.nseindia.com/corporate/MAITREYA_29052026191221_INTERNAL_AUDITOR.pdf) |
| 28 Jul - Maitreya Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, … | [Disclosure under SEBI Takeover Regulations 28 Jul - Maitreya Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, …](https://nsearchives.nseindia.com/corporate/team_bbodade_24072026165953_MAITREYA.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_30539_MAITREYA_2025_2026_A_12914461_24082026132615.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26900_MAITREYA_2024_2025_A_14072025161148.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25279_MAITREYA_2023_2024_2908202417243.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://nsearchives.nseindia.com/corporate/MAITREYA_08092025154527_MML_INVESTOR_PRESENTATION.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/MAITREYA_16112025224335_INVESTOR_PRESENTATION.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://nsearchives.nseindia.com/corporate/MAITREYA_11112024183354_TRANSCRIPT.pdf) |
| May 2024 | [Concall - May 2024](https://nsearchives.nseindia.com/corporate/MAITREYA_29052024162503_PRESENTATION.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://nsearchives.nseindia.com/corporate/MAITREYA_16022024124355_EARNINGCALLTRANSCRIPT.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:36.923Z.